News

New Ozempic alternative only needs to be taken once a month and leads to ‘substantial weight loss’
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
STAT3d
Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...
Amgen Shares Fall on Weight-Loss Drug Tummy Troubles
Amgen shares fell sharply on Monday afternoon after the company released results from a weight-loss trial that showed that ...
Fierce Biotech2d
Amgen rolls out phase 3 dosing plan for lead obesity candidate after midstage trial sees high discontinuation, vomiting rates
While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, ...
Lilly, Novo, and Amgen set for key obesity trial readouts at upcoming ADA event
Novo Nordisk (NVO), and Amgen (NASDAQ:AMGN) are scheduled to present major clinical trial readouts at the American Diabetes ...
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...